The research in this area is being further undertaken to understand the dynamics of the infection better, which is expected to propel the in vitro toxicology research field further.. Due to covid-19 outbreak, there has been a significant increase in Covid-19 testing and drug research. There is a huge increase of manufacturers that have taken key steps to increase patient access to coronavirus diagnostic testing, vaccine and drug development in laboratories, hospitals, and other testing sites across the country to guide patient care and protect public health. On the other hand, we are estimating that the major share of diagnostic assays and molecular testing of Covid-19, along with personalized medicine will grow at a stable pace in the next five years.
According to the new market research report In Vitro Toxicity Testing Market is expected to reach $14.9 billion by 2025, at a CAGR of 10.3%.
The organ toxicity segment is expected to grow at the highest CAGR during the forecast period. The growth in this segment can be attributed to factors such as the consumer-product safety and increasing focus on drug safety, along with the need to screen potential drug targets during the early stage of drug development.
The cell culture technologies segment is estimated to account for the largest market share in 2018. The large share of this segment can be attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions.
The prominent players in the in vitro toxicity testing market include Thermo Fisher Scientific Inc. (US), Covance (US), SGS S.A. (Switzerland), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209577065